Michael Newman, MD
Orthopaedic Surgery · Portland, MENPI 1356392369
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Stryker at 31.6% of the total. Reporting peaked in 2019 at $1,020 and has fallen 89.9% since, to $103 in 2025.
Across 66 payments — averaging $46.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$977
- Zimmer Biomet$743
- Smith+Nephew$539
- Encore Medical, LP$493
- Pacira Pharmaceuticals Incorporated$142
- Acumed LLC$54
- plus $143 from 5 others
What the payments were for
- Food & beverage$2,99497%
- Education$963%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 28 | $977 |
| Zimmer Biomet | 13 | $743 |
| Smith+Nephew | 11 | $539 |
| Encore Medical, LP | 5 | $493 |
| Pacira Pharmaceuticals Incorporated | 2 | $142 |
| Acumed LLC | 1 | $54 |
| Molnlycke Health Care US, LLC | 1 | $45 |
| Pacira Therapeutics, Inc. | 2 | $35 |
| Amgen | 1 | $27 |
| Organogenesis Inc. | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO Surgical Empowr Knee System$374
- Knees-MyMobility$140
- Hips-MyMobility$140
- REAL INTELLIGENCE$122
- Journey II$122
- POLARSTEM$122
- REDAPT$122
- MAKO$119
- EXPAREL$117
How this compares
$3,090 in reported general payments places this provider in the 55th percentile of 111 orthopaedic surgery providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 32 | $230 |
| Oxycodone Hcl | 37 | $189 |
| Amoxicillin | 103 | $90 |
| Meloxicam | 16 | $40 |
| Prednisone | 13 | $36 |
| Tramadol Hcl | 14 | $25 |
| Cephalexin | 14 | $19 |
| Clindamycin Hcl | 17 | $12 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Portland
- Matthew CamusoPortland$120K
- Gregory PomeroyPortland$52K
- Gregory BlaisdellPortland$22K
- Hayley DaniellPortland$16K
- Bruce GombergPortland$9K
- Sarah ShubertPortland$4K
- Bryce WolfPortland$2K
- Urvi PatelPortland$1K
- George BabikianFalmouth$446K
- Nicholas ColacchioFalmouth$439K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.